Neogen raises fiscal 2027 revenue, EBITDA outlook on first-quarter growthOct 21Clinical readoutAbbott LaboratoriesargenxUpdated
China SXT Pharmaceuticals terminates over-allotment option on registered direct offeringOct 21FinancingChina SXT Pharmaceuticals, Inc.
China SXT Pharmaceuticals announces $12 million registered direct offeringOct 8FinancingChina SXT Pharmaceuticals, Inc.
China SXT Pharmaceuticals prices $9 million registered direct offering with warrantsJul 24FinancingChina SXT Pharmaceuticals, Inc.